SLS
SELLAS Life Sciences Group, IncHealthcare$4.13
▲ Bullish
Mkt Cap: $741.7M|Float: 178.8M|SI: 25.6%|DTC: 6.5
Data as of market close Apr 2, 2026
IV Rank
83
IV Pctl
67%
HV 20d
11325.0%
52W Range
$1-$6
ATR(14)
$0.47
Exp. Move
±11.5%
P/C Ratio
0.07
Earnings
May 12
GEX Positive
DEX Long
Net Call Premium
IV High
Max Pain Above
Exp. Move Wide
Low Put/Call
SLS Key Options Data
- IV Rank
- 83.4%
- Total GEX
- $0.03B
- Total DEX
- $36.6M
- Max Pain
- $5.00
- Expected Move
- ±11.5%
- Put/Call OI
- 0.07
- Net Premium
- $0.9M
- Spot Price
- $4.13
Gamma Exposure (GEX)
Delta Exposure (DEX)
Expected Move by Expiration
| Expiration | DTE | Expected Move | Move % | Lower | Upper |
|---|---|---|---|---|---|
| 2026-04-10 | 8 | ±$0.48 | ±11.5% | $3.66 | $4.61 |
| 2026-04-17 | 15 | ±$0.72 | ±17.6% | $3.41 | $4.86 |
| 2026-04-24 | 22 | ±$0.90 | ±21.8% | $3.23 | $5.03 |
| 2026-05-01 | 29 | ±$1.40 | ±33.9% | $2.73 | $5.53 |
| 2026-05-08 | 36 | ±$0.75 | ±18.2% | $3.38 | $4.88 |
| 2026-05-15 | 43 | ±$1.35 | ±32.7% | $2.78 | $5.48 |
Explore SLS options data including implied volatility rankings, gamma and delta exposure, max pain levels, and expected price moves. AI-generated reports provide directional, income, and earnings analysis.